Parkinson’s disease

Apr 29, 2019

Parkinson's Awareness Month April marks Parkinson's Awareness Month, is an occasion to spread awareness about Parkinson’s. Not the early signs as they are more than just any tremor! Parkinson’s changes everything. Over 10 Million people are living with Parkinson’s worldwide yet the condition remains a mystery. ...

Mar 20, 2019

The Cornea- the outermost layer in the human eye, plays an important role in regulating the amount of light entering into the eye. It also protects the eye from germs, dust, and other harmful matter. Although this important part of the human body has a countless number of ways to get damaged. Corneal Abrasions, Dry...

Sep 18, 2018

Argenx gets green cue in phase 2 in primary immune thrombocytopenia The Belgian biotech, Argenx has cleared phase 2 data on efgartigimod in primary immune thrombocytopenia (ITP). The results that they received, indicate at the effectiveness of the antibody Fc fragment in patients with the autoimmune bleeding disord...

Aug 17, 2018

Diverse voltage and ligand gated ion channels mediate Neuron excitation through various ions by sending electrical signals. Calcium is critical for cellular functioning. Voltage-gated calcium channels are primary mediators of depolarization-induced calcium entry into neurons. Calcium ions act as membrane potentiatio...

Aug 01, 2018

‘Reprogrammed’ stem cells to be tested in people with Parkinson’s Doctors in Japan are poised to implant neural cells made from ‘reprogrammed’ stem cells into the brains of people with Parkinson’s disease. It is only the third clinical application of induced pluripotent stem (iPS) cells, which are developed by repro...

Aug 31, 2017

Japanese researchers report promising results from an experimental therapy for Parkinson’s disease that involves implanting neurons made from ‘reprogrammed’ stem cells into the brain. A trial conducted in monkeys with a version of the disease showed that the treatment improved their symptoms and seemed to be safe, a...

Apr 12, 2017

Malaysia calls for phase 4 Dengvaxia study before considering full approval Already struggling to meet initial expectations, Sanofi Pasteur's dengue vaccine Dengvaxia will have to undergo phase 4 testing in Malaysia before the endemic country agrees to sign off on a full approval. Malaysia’s National Pharmaceutical ...